opioid overdose
FDA Approves OTC Version of Opioid Overdose Reversal Agent
The FDA approved the OTC version of naloxone nasal spray to rapidly reverse the effects of opioid overdose.
MARCH 29, 2023
FDA: Risks for Patients Exposed to Xylazine in Illicit Drugs
Xylazine is not approved for human use and may result in serious and life-threatening AEs that appear to be similar ...
NOVEMBER 17, 2022
Expanded Telehealth Services for OUD During the Pandemic Lessened Overdose Risk
Virtual care for opioid use disorder during the COVID-19 pandemic among Medicare beneficiaries decreased odds of ...
SEPTEMBER 9, 2022
COVID-19 Death Toll: More Than Just SARS-CoV-2
More than 100,000 people in the United States died from a drug overdose between April 2020 to April 2021.
NOVEMBER 18, 2021
Load more